Anti-angiogenic effect of caffeic acid on retinal neovascularization

Vascular Pharmacology

Volumn 51, Issue 4, 2009, Pages 262-267

  Kim, Jeong Hun ^a   Lee, Byung Joo ^a   Kim, Jin Hyoung ^a   Yu, Young Suk ^a   Kim, Kyu Won ^b  

^a Seoul National University   (South Korea)

^b Tumor Microenvironment Global Core Research Center   (South Korea)

Author keywords

Anti angiogenic; Anti oxidant; Caffeic acid; Reactive oxygen species; Retinal neovascularization; Vascular endothelial growth factor

Indexed keywords

BETA ACTIN; CAFFEIC ACID; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG POTENCY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; RETROLENTAL FIBROPLASIA; VISUAL IMPAIRMENT;

ANGIOGENESIS INHIBITORS; ANIMALS; CAFFEIC ACIDS; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; RETINAL NEOVASCULARIZATION; RETINAL VESSELS;

EID: 70349983366     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2009.06.010     Document Type: Article

References (22)

1. Abran D., Varma D.R., and Chemtob S. Regulation of prostanoid vasomotor effects and receptors in choroidal vessels of newborn pigs. American Journal of Physiology 272 3 Pt 2 (1997) R995-1001
2. Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., Pasquale L.R., Thieme H., Iwamoto M.A., Park J.E., Nguyen H.V., Aiello L.M., Ferrara N., and King G.L. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New England Journal of Medicine 331 22 (1994) 1480-1487
3. Banskota A.H., Tezuka Y., and Kadota S. Recent progression pharmacological research of propolis. Phytotherapy Research 15 7 (2001) 561-571
4. Buhimschi I.A., Buhimschi C.S., Pupkin M., and Weiner C.P. Beneficial impact of term labor: nonenzymatic antioxidant reserve in the human fetus. American Journal of Obstetrics and Gynecology 189 1 (2003) 181-188
5. Chen J., and Smith L.E. Retinopathy of prematurity. Angiogenesis 10 2 (2007) 133-140
6. Folkman J. Angiogenesis. Annual Review of Medicine 57 (2006) 1-18
7. Gariano R.F., and Gardner T.W. Retinal angiogenesis in development and disease. Nature 438 7070 (2005) 960-966
8. Gibson D.L., Sheps S.B., Uh S.H., Schechter M.T., and McCormick A.Q. Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic. Pediatrics 86 3 (1990) 405-412
9. Jun H.O., Kim Y., Kwon Y.W., Hong S.S., Kim K.W., Shin J., and Kim T.Y. Wondonin, a novel compound, inhibits hypoxia-induced angiogenesis through hypoxia-inducible factor 1 alpha. FEBS Letter 581 25 (2007) 4977-4982
10. Jung J.E., Kim H.S., Lee C.S., Park D.H., Kim Y.N., Lee M.J., Lee J.W., Park J.W., Kim M.S., Ye S.K., and Chung M.H. Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells. Carcinogenesis 28 8 (2007) 1780-1787
11. Kim J.H., Kim K.H., Kim J.H., Yu Y.S., Kim Y.M., Kim K.W., and Kwon H.J. Homoisoflavanone inhibits retinal neovascularization through cell cycle arrest with decrease of cdc2 expression. Biochemical and Biophysical Research Communications 362 4 (2007) 848-852
12. Kim J.H., Kim J.H., Yu Y.S., Park K.H., Kang H.J., Lee H.Y., and Kim K.W. Antiangiogenic effect of deguelin on choroidal neovascularization. Journal of Pharmacology and Experimental Therapeutics 324 2 (2008) 643-647
13. Kim J.H., Kim J.H., Yu Y.S., Shin J.Y., Lee H.Y., and Kim K.W. Deguelin inhibits retinal neovascularization by down-regulation of HIF-1alpha in oxygen-induced retinopathy. Journal of Cellular Molecular Medicine 12 6A (2008) 2407-2415
14. Kim J.H., Kim J.H., Ahn B.J., Park J.H., Shon H.K., Yu Y.S., Moon D.W., Lee T.G., and Kim K.W. Label-free calcium imaging in ischemic retinal tissue by TOF-SIMS. Biophysical Journal 94 10 (2008) 4095-4102
15. Lelkes P.I., Hahn K.L., Sukovich D.A., Karmiol S., and Schmidt D.H. On the possible role of reactive oxygen species in angiogenesis. Advances in Experimental Medicine and Biology 454 (1998) 295-310
16. Min J.K., Cho Y.L., Choi J.H., Kim Y., Kim J.H., Yu Y.S., Rho J., Mochizuki N., Kim Y.M., Oh G.T., and Kwon Y.G. Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice. Blood 109 4 (2007) 1495-1502
17. Roth A.M. Retinal vascular development in premature infants. American Journal of Ophthalmology 84 5 (1977) 636-640
18. Ruef J., Hu Z., Yin L.Y., Wu Y., Hanson S.R., Kelly A.B., Harker L.A., Rao G.N., Runge M.S., and Patterson C. Induction of vascular endothelial growth factor in balloon-injured baboon arteries: a novel role for reactive oxygen species in atherosclerosis. Circulation Research 81 1 (1997) 24-33
19. Shono T., Ono M., Izumi H., Jimi S., Matsushima K., Okamoto T., Kohno K., and Kuwano M. Involvement of the transcription factor NF-kB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Molecular and Cellular Biology 16 8 (1996) 4231-4239
20. Siquet C., Paiva-Martins F., Lima J.L., Reis S., and Borges F. Antioxidant profile of dihydroxy- and trihydroxyphenolic acids - a structure-activity relationship study. Free Radical Research 40 4 (2006) 433-442
21. Smith L.E., Wesolowski E., McLellan A., Kostyk S.K., D'Amato R., Sullivan R., and D'Amore P.A. Oxygen-induced retinopathy in the mouse. Investigative Ophthalmology & Vision Science 35 1 (1994) 101-111
22. Sondheimer E. On the distribution of caffeic acid and the chlorogenic acid isomers in plants. Archives of Biochemistry and Biophysics 74 1 (1958) 131-138